Identity
- Security key
- 19778
- Ticker
- OVID
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2017-05-05
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- OVID
Detail
Enriched 2026-08-14 20:47
- Market cap
- $488,997,067.24
- Shares outstanding (class)
- 186,640,102
- Shares outstanding (weighted)
- 186,640,102
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 23
- Location
- NEW YORK, NY
- Homepage
- https://www.ovidrx.com
- Description
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.